P. Foulc, V. Evrard, Sophie Dalac
Nov 1, 2002
Citations
0
Influential Citations
13
Citations
Journal
British Journal of Dermatology
Abstract
Summary Background Mechlorethamine is frequently used in the treatment of cutaneous lymphoma, but its application is limited in 30–80% of cases because of cutaneous intolerance. Reducing the concentration to avoid this side‐effect has been only modestly successful.